Tower Research Capital (TRC)’s T-Rex 2X Inverse MSTR Daily Target ETF MSTZ Stock Holding History
Bought
Maintained
Sold
Other funds holding MSTZ
Tower Research Capital (TRC)'s MSTZ Position: Q1 2026 in Review
Tower Research Capital (TRC) sold out of T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) in Q1 2026, closing a stake of 5,794 shares — an estimated $99.4K sold.
Tower Research Capital (TRC) first reported a position in MSTZ in Q4 2024 and held it in 5 quarters. The position peaked at $99.4K in Q4 2025. 16 funds tracked by Wall St. Rank hold MSTZ as of Q1 2026.
- Tower Research Capital (TRC) reported no remaining T-Rex 2X Inverse MSTR Daily Target ETF position as of Q1 2026 after selling out during the quarter.
- Tower Research Capital (TRC) sold 5,794 T-Rex 2X Inverse MSTR Daily Target ETF shares in Q1 2026, an estimated $99.4K.
- Tower Research Capital (TRC) first reported a position in T-Rex 2X Inverse MSTR Daily Target ETF in Q4 2024 and held it in 5 quarters.
- Tower Research Capital (TRC)'s T-Rex 2X Inverse MSTR Daily Target ETF position peaked at $99.4K in Q4 2025.
- 16 funds tracked by Wall St. Rank held T-Rex 2X Inverse MSTR Daily Target ETF as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.